Regulatory Rapporteur September 2019
FOCUS: Ireland's regulatory framework PLUS • Interview: David Mukanga from the Gates Foundation, Africa • Profile: FDA's Ned Sharpless
Regulatory Rapporteur September 2019MEMBERS
Ireland’s ambitions and innovation for drug and research developmentMEMBERS
EU cooperation on health technology assessment and beyondMEMBERS
Recent revisions to legislation impacting the pharmaceutical industry in SwitzerlandMEMBERS
The science of complianceMEMBERS
Regulatory Science Ireland and the regulatory dilemma for future innovative therapeuticsMEMBERS
Physician-scientist takes the lead at the US FDAMEMBERS
Building regulatory systems in Africa PUBLIC
Editorial: Ireland at the forefront of regulatory affairs PUBLIC
Public health protection through effective regulation PUBLIC
Highlights from TOPRA regulatory intelligence roundtable meeting PUBLIC